Polyreactivity and immunoglobulin variable region gene usage in human CD5+ B cells.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F99%3A00000021" target="_blank" >RIV/00023728:_____/99:00000021 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Polyreactivity and immunoglobulin variable region gene usage in human CD5+ B cells.
Original language description
B-lymphocytes that express the pan T cell glycoprotein CD5 (CD5+ or B1 cells) show a variety of features that distinguish them from the bulk of conventional CD5- B cells (B2 cells). Among these are a distinctive surface phenotype and a propensity to produce antibodies that react with low avidity to multiple antigens including self-antigens (i.e.) polyreactive or natural antibodies) which could lead to pathogenic autoantibodies found in autoimmune diseases. Studies on foetal, cord blood and leukaemiaB cells, which express the CD5+ marker implied that: a) number of immunoglobulin variable region (IgV) genes are preferentially expressed in CD5+ B cells; and b) that the production of polyreactive antibodies may be an exclusive feature of CD5+ cells. Studies presented here show that whilst IgV genes in germline, or near germline, configuration that often encode natural antibodies are expressed at high frequency, in CD5+ B cells, the expression of these genes is not restricted to CD5+ B cell
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FN - Epidemiology, infection diseases and clinical immunology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/IZ3638" target="_blank" >IZ3638: Methotrexate and cyclosporine A in the management of polymyositis and dermatomyositis and new possibilities of asseesing disease activity</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
1999
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Trans-Caucasian Journal of Immunology
ISSN
—
e-ISSN
—
Volume of the periodical
1
Issue of the periodical within the volume
1
Country of publishing house
GE - GEORGIA
Number of pages
18
Pages from-to
—
UT code for WoS article
—
EID of the result in the Scopus database
—